Efficacy and Safety of Micropulse Trans-Scleral Cyclophotocoagulation in Cambodian Patients with Glaucoma  

作　　者：Channdarith Kith Meng Ngy Kossama Chukmol Bunseng Sea Piseth Kong Ponndara Ith Channdarith Kith;Meng Ngy;Kossama Chukmol;Bunseng Sea;Piseth Kong;Ponndara Ith(Department of Ophthalmology, Preah Ang Duong Hospital, Phnom Penh, Cambodia;Department of Ophthalmology, Khmer-Soviet Friendship Hospital, Phnom Penh, Cambodia;Faculty of Medicine, University of Health Sciences, Phnom Penh, Cambodia)

机构地区：[1]Department of Ophthalmology, Preah Ang Duong Hospital, Phnom Penh, Cambodia [2]Department of Ophthalmology, Khmer-Soviet Friendship Hospital, Phnom Penh, Cambodia [3]Faculty of Medicine, University of Health Sciences, Phnom Penh, Cambodia

出　　处：《Open Journal of Ophthalmology》2024年第3期268-283,共16页眼科学期刊（英文）

摘　　要：Objective: To evaluate the treatment outcomes of micropulse cyclophotocoagulation in Cambodian glaucoma patients. Materials and Methods: 14 patients were enrolled in this retrospective study that was conducted with the consent over a 14-month period. The medical records were analyzed for variables such as intra-ocular pressure, the number of anti-glaucoma drugs used, visual acuity, pain level, and complications during and after treatment. The main outcome was whether or not there was success or failure, with success being defined as a pressure level between 6 and 21 mmHg and a 30% decrease in IOP by week 24 (with/without drugs). Results: In our study, the mean age of patients was 52.36 ± 9.98 years old (42 to 75 years old). The mean intra-ocular pressure before treatment was 41.00 ± 12.26 mmHg, which decreased to 21.60 ± 8.11 mmHg (41.56% reduction) and 16.94 ± 5.46 mmHg (56.04% reduction) in the 12th and 24th weeks (p p Conclusion: Micro-pulse trans-scleral cyclophotocoagulation is a safe and effective method for lowering pressure in any stage of disease without the use of invasive surgeries.Objective: To evaluate the treatment outcomes of micropulse cyclophotocoagulation in Cambodian glaucoma patients. Materials and Methods: 14 patients were enrolled in this retrospective study that was conducted with the consent over a 14-month period. The medical records were analyzed for variables such as intra-ocular pressure, the number of anti-glaucoma drugs used, visual acuity, pain level, and complications during and after treatment. The main outcome was whether or not there was success or failure, with success being defined as a pressure level between 6 and 21 mmHg and a 30% decrease in IOP by week 24 (with/without drugs). Results: In our study, the mean age of patients was 52.36 ± 9.98 years old (42 to 75 years old). The mean intra-ocular pressure before treatment was 41.00 ± 12.26 mmHg, which decreased to 21.60 ± 8.11 mmHg (41.56% reduction) and 16.94 ± 5.46 mmHg (56.04% reduction) in the 12th and 24th weeks (p p Conclusion: Micro-pulse trans-scleral cyclophotocoagulation is a safe and effective method for lowering pressure in any stage of disease without the use of invasive surgeries.

关 键 词：PHOTOCOAGULATION GLAUCOMA EFFICACY Safety Intra-Ocular Pressure Micro Pulse 

分 类 号：R73[医药卫生—肿瘤]